Ha habido 50 transacciones internas recientes registradas para Personalis, Inc. (PSNL), incluyendo 28 compras y 21 ventas. El total de compras internas fue valorado en $9.13M y el total de ventas internas en $13M.
Internos destacados con actividad reciente incluyen Tachibana Aaron, Hall Christopher M, Chen Richard. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — PSNL
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-15 |
Tachibana Aaron |
CFO and COO |
Concesión de RSU |
34,375 |
- |
- |
198,833 |
| 2026-03-15 |
Hall Christopher M |
Chief Executive Officer |
Concesión de RSU |
87,500 |
- |
- |
235,986 |
| 2026-03-15 |
Chen Richard |
President and CMO |
Concesión de RSU |
46,875 |
- |
- |
173,880 |
| 2026-03-15 |
Moore Stephen Michael |
SVP and Chief Legal Officer |
Concesión de RSU |
28,125 |
- |
- |
92,325 |
| 2026-02-23 |
Tachibana Aaron |
CFO and COO |
Concesión de RSU |
15,000 |
$1.61 |
$24.15K |
15,000 |
| 2026-02-23 |
Hall Christopher M |
President and CEO |
Concesión de RSU |
33,333 |
$1.61 |
$53.67K |
33,333 |
| 2026-02-23 |
Chen Richard |
Chief Medical Officer and EVP |
Concesión de RSU |
15,000 |
$1.61 |
$24.15K |
15,000 |
| 2026-02-23 |
Moore Stephen Michael |
SVP and Chief Legal Officer |
Concesión de RSU |
8,333 |
$1.61 |
$13.42K |
8,333 |
| 2026-01-22 |
Tachibana Aaron |
CFO and COO |
Ejercicio de Opciones (Venta) |
1,201 |
$9.16 |
$11K |
107,631 |
| 2025-12-22 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
28,000 |
$8.93 |
$250.04K |
13,039,067 |
| 2025-12-19 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
29,641 |
$8.39 |
$248.69K |
13,011,067 |
| 2025-12-18 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
31,430 |
$7.91 |
$248.61K |
12,981,426 |
| 2025-12-17 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
31,650 |
$7.86 |
$248.77K |
12,949,996 |
| 2025-11-25 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
9,712 |
$10.08 |
$97.9K |
12,904,458 |
| 2025-11-25 |
Tachibana Aaron |
CFO and COO |
Ejercicio de Opciones (Venta) |
103,668 |
$9.16 |
$949.6K |
108,832 |
| 2025-11-24 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
25,225 |
$9.87 |
$248.97K |
12,894,746 |
| 2025-11-21 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
9,900 |
$8.84 |
$87.52K |
12,852,922 |
| 2025-11-20 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
28,827 |
$8.63 |
$248.78K |
12,843,022 |
| 2025-11-19 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
30,645 |
$8.12 |
$248.84K |
12,814,195 |
| 2025-11-18 |
Tempus Ai, Inc. |
10 Percent Owner |
Compra Informativa |
64,750 |
$7.67 |
$496.63K |
12,783,550 |
| 2025-11-03 |
Hall Christopher M |
President and CEO |
Venta Informativa |
29,612 |
$8.99 |
$266.21K |
148,486 |
| 2025-07-28 |
Tachibana Aaron |
CFO and COO |
Venta Informativa |
641 |
$6.57 |
$4.21K |
164,458 |
| 2025-07-28 |
Chen Richard |
Chief Medical Officer and EVP |
Venta Informativa |
452 |
$6.57 |
$2.97K |
124,505 |
| 2025-05-16 |
Bowman A Blaine |
Director |
Concesión de RSU |
50,000 |
$4.95 |
$247.5K |
50,000 |
| 2025-05-16 |
Widder Kenneth J |
Director |
Concesión de RSU |
50,000 |
$4.95 |
$247.5K |
50,000 |
| 2025-05-16 |
Eastham Karin |
Director |
Concesión de RSU |
50,000 |
$4.95 |
$247.5K |
50,000 |
| 2025-05-16 |
Myers Woodrow A Jr |
Director |
Concesión de RSU |
50,000 |
$4.95 |
$247.5K |
50,000 |
| 2025-05-16 |
Tachibana Aaron |
CFO and COO |
Venta Informativa |
1,291 |
$4.95 |
$6.39K |
165,099 |
| 2025-05-16 |
Shoff Lonnie |
Director |
Concesión de RSU |
50,000 |
$4.95 |
$247.5K |
50,000 |
| 2025-05-16 |
Bloom Olivia Kyusuk |
Director |
Concesión de RSU |
50,000 |
$4.95 |
$247.5K |
50,000 |
| 2025-05-16 |
Chen Richard |
Chief Medical Officer and EVP |
Venta Informativa |
910 |
$4.95 |
$4.5K |
124,957 |
| 2025-05-16 |
Moore Stephen Michael |
SVP and Chief Legal Officer |
Venta Informativa |
1,675 |
$4.95 |
$8.29K |
64,200 |
| 2025-03-15 |
Tachibana Aaron |
CFO and COO |
Concesión de RSU |
250,000 |
$3.63 |
$907.5K |
250,000 |
| 2025-03-15 |
Hall Christopher M |
President and CEO |
Concesión de RSU |
680,000 |
$3.63 |
$2.47M |
680,000 |
| 2025-03-15 |
Chen Richard |
Chief Medical Officer and EVP |
Concesión de RSU |
250,000 |
$3.63 |
$907.5K |
250,000 |
| 2025-03-15 |
Moore Stephen Michael |
SVP and Chief Legal Officer |
Concesión de RSU |
225,000 |
$3.63 |
$816.75K |
225,000 |
| 2025-01-28 |
Tachibana Aaron |
CFO and COO |
Venta Informativa |
708 |
$5.79 |
$4.1K |
166,390 |
| 2025-01-28 |
Chen Richard |
Chief Medical Officer and EVP |
Venta Informativa |
519 |
$5.79 |
$3.01K |
123,367 |
| 2024-12-19 |
Merck & Co., Inc. |
10 Percent Owner |
Desconocido |
- |
- |
- |
14,044,943 |
| 2024-12-16 |
Tachibana Aaron |
CFO and COO |
Venta Informativa |
6,865 |
$3.82 |
$26.22K |
167,098 |
| 2024-12-16 |
Chen Richard |
Chief Medical Officer and EVP |
Venta Informativa |
4,834 |
$3.82 |
$18.47K |
123,886 |
| 2024-12-16 |
Moore Stephen Michael |
SVP and Chief Legal Officer |
Venta Informativa |
1,513 |
$3.82 |
$5.78K |
65,875 |
| 2024-11-18 |
Tachibana Aaron |
CFO and COO |
Venta Informativa |
1,307 |
$3.79 |
$4.95K |
173,963 |
| 2024-11-18 |
Chen Richard |
Chief Medical Officer and EVP |
Venta Informativa |
921 |
$3.79 |
$3.49K |
128,720 |
| 2024-11-18 |
Moore Stephen Michael |
SVP and Chief Legal Officer |
Venta Informativa |
1,693 |
$3.79 |
$6.42K |
67,388 |
| 2024-11-01 |
Hall Christopher M |
President and CEO |
Venta Informativa |
26,443 |
$5.38 |
$142.26K |
178,098 |
| 2024-08-16 |
Tempus Ai, Inc. |
10 Percent Owner |
Ejercicio de Opciones (ITM) |
4,609,400 |
$2.50 |
$11.52M |
- |
| 2024-07-30 |
Tachibana Aaron |
CFO and COO |
Venta Informativa |
742 |
$2.97 |
$2.2K |
175,270 |
| 2024-07-30 |
Chen Richard |
Chief Medical Officer and EVP |
Venta Informativa |
524 |
$2.97 |
$1.56K |
127,227 |
| 2024-06-17 |
Tachibana Aaron |
CFO and COO |
Venta Informativa |
7,176 |
$1.29 |
$9.26K |
176,012 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
